Effect on testosterone levels
The measurement of testosterone levels of serum from rats showed that there was not a significant difference at both doses of
Rosmarinusofficinalis in comparison with control group at the early period of experiment. Nevertheless, at the mid-term of experiment, testosterone level was decreased significantly at dose of 100 mg/Kg b.w (3.2300 ± 0.1959 pg/mL), when compared with control group. This decreasing was not significant at dose of 50 mg/Kg b.w. Serum testosterone levels were decreased significantly at both doses of 50 and 100 mg/Kg b.w at the late period of experiment (3.1514 ± 0.4060 pg/mL and 2.4457 ± 0.2219 pg/mL, respectively) in comparison with control group (
Table 1).
| Treatment | Dose | Early period | Mid-term | Late period |
|---|
| Control group | 10 mL/Kg b.w | 4.1575 ± 0.3120 | 4.1575 ± 0.3214 | 4.4113 ± 0.3344 |
| Group A (Rosmarinus officinalis) | 50 mg /Kg b.w | 4.1471 ± 0.2468 | 3.7114 ± 0.3492 | 3.1514 ± 0.4060* |
| Group B (Rosmarinus officinalis) | 100 mg/Kg b.w | 4.0757 ± 0.0763 | 3.2300 ± 0.1959* | 2.4457 ± 0.2219* |
Sperm properties
Effect on epididymal sperm count
Results showed that the Vasa deferentia sperm count was not significantly changed when treated with
Rosmarinus officinalis at both dose levels. That is,
Rosmarinus officinalis at the doses of 50 and 100 mg/Kg b.w showed about 58.30 ± 0.33 × 10
6 and 60.10 ± 0.19 × 10
6 sperm/ mL, respectively, in comparison with control (59.50 ± 0.29 × 10
6 sperm/mL) (
Table 2).
| Treatment | Dose | Total count (Total sperm of rat × 106) | Sperm motility (%) | Sperm Livability (%) |
|---|
| Control group | 10 mL/Kg b.w | 59.50 ± 0.29 | 63.13 ± 1.86 | 67.13 ± 1.66 |
| Group A (Rosmarinus officinalis) | 50 mg /Kg b.w | 58.30 ± 0.33 | 62.14 ± 0.98 | 65.43 ± 0.81 |
| Group B (Rosmarinus officinalis) | 100 mg/Kg b.w | 60.10 ± 0.19 | 59.14 ± 0.40 | 64.00 ± 0.30 |
Effect on motility and viability of sperm
In rats from control group, Vasa deferentia sperm exhibited rapid progressive motility and it was lasted for about 1 h and 20 min. In the rat treated with Rosmarinus officinalis at doses of 50 and 100 mg/Kg b.w, the sperms showed the same progressive motility for 75 ± 4 min.
Although the motility and viability of sperm were declined concurrently following the dose increasing, there was no significant difference between the percentage of sperm motility and viability of both treatment groups in comparison with control group (
Table 2).
Effect on testicular cell population
Histological findings showed that there is a significant difference between the number of Spermatogonia at both doses of 50 and 100 mg/Kg b.w (76.13 ± 3.88 and 65.25 ± 2.22, respectively), Spermatocyte at dose of 50 mg/Kg b.w (91.25 ± 2.46) and Spermatid cells at dose of 100 mg/Kg b.w (246.13 ± 3.07), compared to the control group (
Table 3). However, the number of the Spermatozoid and Sertoli cells did not changed significantly in comparison with control group at the same time. Leydig cells were also increased significantly at the dose of 100 mg/Kg b.w (34.25 ± 2.15) and insignificantly at dose of 50 mg/Kg b.w (26.75 ± 2.16) in comparison with the control group (
Table 3).
| Treatment | Dose | Spermatogonia | Spermatocyte | Spermatid | Spermatozoid | Sertoli cell | Leydig cell |
|---|
| Control group | 10 mL/Kg b.w | 48.63 ± 2.49 | 67.50 ± 4.22 | 215.00 ± 17.51 | 146.63 ± 8.48 | 11.63 ± 0.65 | 19.75 ± 4.90 |
| Group A (Rosmarinus officinalis) | 50 mg /Kg b.w | 76.13 ± 3.88* | 91.25 ± 2.46* | 353.50 ± 4.65 | 129.50 ± 1.83 | 15.00 ± 2.43 | 26.75 ± 2.16 |
| Group B (Rosmarinus officinalis) | 100 mg/Kg b.w | 65.25 ± 2.22* | 75.75 ± 2.90 | 246.13 ± 3.07* | 135.50 ± 2.40 | 13.88 ± 1.02 | 34.25 ± 2.15* |
Testes, body weight and their ratio
The results of this study revealed that there were no significant differences found between the initial and final proportion of testes weight to body weights of rat treated with Rosmarinusofficinalis at both doses compared to control group. Meanwhile, the extract of Rosmarinusofficinalis at the doses of 50 and 100 mg/Kg b.w had no effect on the ratio of Testis Weights to
| Treatment | Dose | Testis weight to body weight ratio |
| Control group | 10 mL/Kg b.w | 0.5125 ± 0.0240 |
| Group A (Rosmarinus officinalis) | 50 mg /Kg b.w | 0.4957 ± 0.0158 |
| Group B (Rosmarinus officinalis) | 100 mg/Kg b.w | 0.5114 ± 0.0246 |
The aim of the present research was to evaluate the effects of
Rosmarinus officinalis extract on hormonal and cellular function of testes in rats.
Rosmarinus officinalis is a typical Mediterranean species, which is now cultivated all over the world. It presents a high genetic variability, which is reflected in the chemical composition of the different individuals, and probably in its biological activity. This plant is used as a spice and traditional medicine around the world, as well as in cosmetics. In medicine, the extract of
Rosmarinus officinalis has been attended due to its antimicrobial, anti-inflammatory and antioxidative component (
8).
The antioxidant properties of
Rosmarinusofficinalis have been well documented, and there are several reports that have established carnosic acid as the major phenolic diterpenoid present in rosemary leaves with antioxidant activity (
9). Recently, this phenolic compound has attracted wide interest as a potential therapeutic agent against several diseases, and research was started to investigate new biological activities. Studies showed that it has chemopreventive, antineoplastic (
10-
11) and radioprotectiveantimutagenic effects (
12).
Hardy
et al. and McLachlan
et al. showed that the dramatic increase in adult Leydig cell number after neonatal PTU (6-propyl-2- thiouracil) treatment is counterbalanced by a permanent decline in Leydig cell steroidogenic function, producing no net change in peripheral testosterone levels. It seems that
Rosmarinusofficinalis in lower doses than 250 mg/Kg b.w reduces the testosterone. This reduction increases LH indirectly which causes the Leydig cell to increase. However, dysfunction of Leydig cells and lack of proper and adequate secretion of testosterone hormone are the main reasons for the reducing of testosterone hormone. On the other hand, FSH is also increased concurrently with the initial increase in LH. FSH increases spermatogenesis process and transforming of spermatogoni to spermatid. Although the number of these two recent cells is increased, spermatogenesis process is declined due to the lack of testosterone hormone and the population of spermatozoa cells eventually is decreased steeply (
13-
14).
In the present study, findings showed that there is no significant difference in the view of total number of spermatozoa between the treatment (50, 100 mg/Kg b.w) and control groups. Number of sperms had been decreased in treatment groups; however it was not significant. Nusier
et al. investigated the effect of ingesting an extract of
Rosmarinus officinalis leaves on fertility and sexual maturation in the male rat. Their result showed that the administration of
Rosmarinus officinalis extract at doses of 250 and 500 mg/Kg b.w caused a significant decrease in the germinal cell population (
15). Our study showed that sperm motility was not significantly decreased in treatment groups in comparison with control. Although the sperm motility was declined in both treatment groups, it was not significant. However, Nusier
et al. (2007) showed that sperm motility at dose of 500 mg/Kg b.w in cauda epididymis, sperm density, seminiferous tubule diameter, Leydig cell nuclear diameter, and epithelial cell height in epididymides (cauda and caput) and seminal vesicles were significantly decreased in treatment groups in comparison with controls (
15). In addition, our results showed that there is no significant difference between all groups in the view of sperm viability.
Histological investigations showed that administration of Rosmarinus officinalis extract at both treatment groups caused a significant decrease in the germinal cell population. Spermatocytes (primary and secondary), spermatids and spermatogonia were decreased significantly. In addition, the numbers of Leydig cells were also significantly increased at 100 mg/ Kg b.w. The number of spermatozoa and sertoli cells, however, was not significantly different between the treatment and control groups.
Findings of Nusier
et al. showed that the administration of
Rosmarinus officinalis extract had no significant effect on the body weights of treated males in comparison with control group. However, the absolute and relative weights of testes, epididymides, seminal vesicles, ventral prostates, and vas deferens were significantly reduced at doses of 500 mg/Kg b.w. Nevertheless, our results do not show considerable changes of sexual organ weights of male rats (
15). Comparative hormonal studies of present study illustrated that there is a significant difference between the treatment and control groups. Testosterone hormone was declined significantly in both treatment groups in comparison with control group. This difference was even extremely significant at 100 mg/Kg b.w.
Rosmarinus officinalis has active components include Caffeic acid derivatives, Diterpenes (bitter) Flavonoids, phenolic compounds, Triterpenes and Volatile oil (
16-
17). Pathak
et al. identified four new compounds from the stems of Dalbergia cochinchinensis which are 9-hydroxy-6, 7-dimethoxydalbergiquinol, 6-hydroxy-2, 7-dimethoxyneoflavene, 6, 4′-dihydroxy-7-methoxyflavan and 2, 2′, 5-trihydroxy-4-methoxybenzophenone, in addition to eight known phenolic compounds including 7-hydroxy-6-methoxyflavone. The first two compounds showed potent inhibitory activity towards 5α-dihydrotestosterone (DHT) which binds with an androgen receptor to form a DHT-receptor complex that causes androgendependent diseases (
18).
In another survey, Gumbinger
et al. showed that the antigonadotropic activity of Lithospermum and Lycopus species can be attributed to their phenolic components like rosmarinic acid which is common with
Rosmarinus officinalis. These compounds represent precursors of biologically active products which are formed by an oxidation step. Complexity and instability of these products aggravates the elucidation of detailed structural properties. Therefore, the type of reaction involved had to be clarified. Among the oxidation products of phenolic substances, the corresponding quinones are found. It can be demonstrated that the reaction between quinones and unoxidized diphenols yields products with strong antigonadotropic activity. This type of reaction - the formation of quinhydrones – is proposed to be engaged in the formation of various products with antigonadotropic activity (
19).
Nahrstedt
et al. identified two new cyclolignan derivatives from the mixture of substances obtained after oxidation of caffeic acid. Their structures were elucidated by spectroscopic methods as 2, 3-dicarboxy-6, 7-dihydroxy-1-(3›, 4’-dihydroxy)-phenyl-1, 2-dihydronaphthalene and 3-carboxy-6,7-dihydroxy-1-(3›, 4’-dihydroxy)-phenylnaphthalene. They exhibit antigonadotropic activity as do the extracts of crude drugs of Lycopus europaeus and Lithospermum officinale after oxidation by plant enzymes (
20). Of course, since the permeability characteristics of blood testes barrier could be determinant in reproductive effects of drugs and environmental chemicals, it is recommended that each of active derivatives should be tested regarding to blood testes barrier (
21). In conclusion, the results suggest that the extract of
Rosmarinus officinalis may have antiandrogenic activity at doses of 50 and 100 mg/Kg b.w on fertility in male rats indicating the possibility of developing herbal male contraceptive. However, these doses of
Rosmarinus officinalis cannot affect the spermatogenesis process. Further studies are needed to investigate the effect of
Rosmarinus officinalis on fertility in male rats at more several doses and to determine its mechanism of action.